Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

OKANOGAN DIALYSIS LLC

NPI: 1861749194 · LAUDERDALE LAKES, FL 33313 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/06/2012

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more

$18.67M
Total Medicaid Paid
139,614
Total Claims
17,824
Beneficiaries
17
Codes Billed
2018-01
First Month
2024-03
Last Month

Provider Details

Authorized OfficialWINSTEL, JOHN (CHIEF ACCOUNTING OFFICER)
NPI Enumeration Date08/06/2012

Related Entities

Other providers sharing the same authorized official: WINSTEL, JOHN

ProviderCityStateTotal Paid
TOTAL RENAL CARE INC INGLEWOOD CA $22.54M
TOTAL RENAL CARE INC MIAMI FL $16.77M
DVA HEALTHCARE RENAL CARE INC LOS ANGELES CA $14.01M
DVA HEALTHCARE RENAL CARE INC BURBANK CA $10.72M
DVA HEALTHCARE RENAL CARE INC OAKLAND CA $10.67M
DVA HEALTHCARE RENAL CARE INC WESTMINSTER CA $8.32M
DVA HEALTHCARE RENAL CARE INC APPLE VALLEY CA $6.93M
DVA HEALTHCARE RENAL CARE INC GLENDALE CA $5.32M
RENAL TREATMENT CENTERS CALIFORNIA INC SANTA ANA CA $5.08M
DVA HEALTHCARE RENAL CARE INC BERKELEY CA $4.25M
TOTAL RENAL CARE INC PLANTATION FL $4.08M
DVA RENAL HEALTHCARE INC LOS ANGELES CA $4.01M
DVA HEALTHCARE OF MASSACHUSETTS INC SALEM MA $3.57M
DVA RENAL HEALTHCARE INC SIERRA VISTA AZ $3.52M
RENAL TREATMENT CENTERS-SOUTHEAST, LP. PANAMA CITY FL $3.14M
WESTON DIALYSIS CENTER LLC WESTON FL $3.01M
BEVERLY HILLS DIALYSIS PARTNERSHIP BEVERLY HILLS CA $2.90M
RENAL TREATMENT CENTERS CALIFORNIA INC EL MONTE CA $2.82M
TOTAL RENAL CARE INC ANTIOCH CA $2.72M
DVA HEALTHCARE RENAL CARE INC PHILADELPHIA PA $2.30M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 20,010 $2.78M
2019 34,182 $3.82M
2020 33,123 $4.41M
2021 25,810 $2.43M
2022 19,376 $4.43M
2023 6,447 $741K
2024 666 $58K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
90999 Unlisted dialysis procedure, inpatient or outpatient 38,256 2,475 $6.61M
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) 44,853 1,885 $5.18M
J1270 Injection, doxercalciferol, 1 mcg 26,512 1,631 $2.95M
A4657 Syringe, with or without needle, each 6,391 2,023 $1.10M
J1756 Injection, iron sucrose, 1 mg 9,023 1,475 $892K
85041 2,540 1,496 $334K
85048 2,539 1,493 $333K
83540 1,978 1,134 $265K
83550 1,978 1,134 $265K
83970 1,836 1,087 $265K
82728 1,903 1,109 $259K
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 1,298 624 $155K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 330 159 $42K
82108 84 35 $8K
G0008 Administration of influenza virus vaccine 35 26 $7K
90674 36 26 $5K
J0887 Injection, epoetin beta, 1 microgram, (for esrd on dialysis) 22 12 $4K